Background: To present the maximum tolerated dose(MTD), safety, and efficacy of 5-Fu continuously pump infusion via superficial temporal artery cannula for high T staged nasopharyngeal ...

Pump malfunctions during 5-FU infusion occurred in 16% of patients treated with FOLFOX-4. The malfunction rate was consistent across cycles (1.3–4.9%) and over time ( Figure 5 ).

Administration of 5-FU involves a central line, an infusion pump, and multiple visits to the physician; all of these things add to the cost of the drug, he explained.

A poster presentation indicates that a new drug, vistonuridine, is an effective antidote for 5-FU overdose, even when the expected outcome was death.

The problem addressed. 3.1 The purpose of this assessment is to evaluate the clinical and cost effectiveness of the My5‑FU assay for the pharmacokinetic dose adjustment of continuous infusion ...

Patients with metastatic gastrointestinal cancer may not need a 5-FU bolus as part of their ... 1%), FOLFIRI (18.2%) or FOLFIRINOX (13.7%) regimens, which can include the 5-FU bolus and infusion.

The 5-FU-infusion in combination with cytostatic agents like oxaliplatin or irinotecan in patients with colorectal cancer is complicated and needs support and a pump for the patient, he said.

A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00–10:00) flat infusion of 5-fluorouracil (5 ...

Saladax Biomedical's MY5-FU blood test will help personalize and optimize 5-fluorouracil dosing in cancer patients. Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is ...

For decades, the most effective treatment for gastrointestinal cancers was a combination of two forms of 5-fluorouracil: the 5-FU bolus injection, followed by the 5-FU continuous infusion.